Subcutaneous IGF-1 is not beneficial in 2-year ALS trial

标题
Subcutaneous IGF-1 is not beneficial in 2-year ALS trial
作者
关键词
-
出版物
NEUROLOGY
Volume 71, Issue 22, Pages 1770-1775
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2008-11-25
DOI
10.1212/01.wnl.0000335970.78664.36

向作者/读者发起求助以获取更多资源

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started